The Psychedelic-Assisted Psychotherapy Research Registry is a project developed and led by researchers at The Australian National University (ANU) and supported by the National Health and Medical Research Council and Mind Medicine Australia. It is designed for the collection of outcome and safety data on the use of novel interventional pharmacotherapy approaches, including ketamine treatment and psychedelic-assisted therapy for mental health disorders such as depression, Post Traumatic Stress Disorder (PTSD) and Obsessive Compulsive Disorder (OCD).
The Registry will allow the conduct of retrospective research studies on the safety and outcomes of these novel treatments. These future studies will involve analyses of the recorded information of individuals undergoing psychedelic therapy included in the Registry, to promote safe and effective treatment options for individuals with these conditions.
Participation in the Registry involves the collection of de-identified personal and medical information about the mental health history of individual participants and their treatment with ketamine or PAPTx.